Skip to content

Agilent Technologies, Inc. (A) Company Overview

Company Analysis

Agilent Technologies, Inc. A

A comprehensive view of key metrics, scores, and financial health for Agilent Technologies, Inc.

Overview of Agilent Technologies, Inc.

A NYQ
Healthcare Diagnostics & Research Framework: Medical Devices & Diagnostics Large Cap
Agilent Technologies, Inc. (A), is a Large Cap company, in the Diagnostics & Research industry, last closed at $171.99, about 74.8% overvalued vs fair value, +16.6% 1Y return, placing in the top 25% of its sector.
Metrics P/E 32.0× Rev Growth 6.7% ROE 20.6% Gross Margin 52.4% Div Yield 0.68%
USD 171.99
-1.65%
(Delayed)
• Vol 90d: 28.3%
52-Week Range
Market Cap
$48.49B
Enterprise Value
$50.68B
Overall Score
Overall
Growth
Fair
Profitability
Good
Health
Good
Efficiency
Fair
Valuation
Good
Growth
Fair
Profitability
Good
Health
Good
Efficiency
Fair
Valuation
Good
Completeness: 100%
Confidence: 97%
Updated: Oct 31
Top Beats

Quick Facts

HQ Santa Clara, CA
Employees 18,000
Fiscal year Oct 31

Next Events

Earnings Nov 23 Call: Nov 23

Fair Value Snapshot

Bear Base Bull
$39
$43
$48
Current: $171.99 -75% vs base

Engine Room Money Flow™

Large Cap

Medical Devices & Diagnostics - Where revenue goes and how value is created

Flow Steps
Total Revenue
$6.9B
6.7%%
Gross Profit
$3.6B
3.1%%
Operating Income (GAAP)
$1.5B
-0.6%%
EBITDA
$1.8B
-2.1%%
Money Flow Bridge
Flow Direction: Money moves from left to right
Components: Breakdown shows composition of each stage
Industry-Specific: Medical Devices & Diagnostics

Quality & Reliability Indicators

Gross Margin
52.4%
Good

Gross Profit / Revenue — primary moat signal for MedTech. ≥65% indicates IP-protected consumables with strong pricing power.

Locked Metric
-
Premium
Locked Metric
-
Premium
Locked Metric
-
Premium
Locked Metric
-
Premium
Locked Metric
-
Premium
Locked Metric
-
Premium

Owner's Pocket - Capital Allocation

Total Returned to Shareholders

Combined dividends, buybacks, and debt reduction

$707.0M
61.4% of Free Cash Flow

Where It Leaks

Cash Flow Health healthy
Strong cash conversion with minimal leakage across profit-to-cash-to-value chain.
1
Active Leaks
0/1
Improving
0
High Impact
0
Critical
Moat Analysis Medical Devices & Diagnostics

Competitive Advantage Assessment

Evaluating Agilent Technologies, Inc.'s durable competitive advantages across 6 defense dimensions

Overall Moat Strength
70
/100
Moderate
Scores based on quantitative metrics and qualitative factors

Key strengths

  • Superior Capital Returns Capital return quality is top-tier (score 0.86). High ROIC indicates the business is reinvesting at attractive rates.
  • Strong FCF Generation FCF margin quality is top-tier vs peers (score 0.85). High FCF conversion confirms strong earnings quality.

Key risks

  • Declining FCF Margin FCF trend score is negative (score 0.24). Declining FCF margin warrants scrutiny of capital allocation discipline.
  • Elevated Leverage Leverage is elevated vs peers (score 0.39). High net debt/EBITDA limits the balance sheet's acquisition firepower.

The dashed ring is the peer median. Defense scores are percentile ranks against peers, so 50 is roughly the typical company in this group.

Upgrade to unlock the signals and evidence behind each defense.

Premium access

Unlock full defense analysis

Get key signals, strengths, and risks for every moat dimension.

Upgrade to Premium Unlock all moat defenses and evidence.

Pricing Power & Consumable Moat

Moderate
66

Trade-Off Ledger™

Where management spends the performance budget - Growth, Profitability, or Safety

Healthcare: MedTech (Devices & Supplies) vs Industry Peers 100% Coverage
Trade-Off Triangle Visualization A ternary plot showing A's balance between Growth (24.4%), Profitability (42.7%), and Safety (32.9%). Growth 24% Safety 33% Profitability 43%

Click axes to expand details. Marker shows current allocation.

3-Year Trend Analysis Locked
Upgrade to unlock the full 3-year trend analysis and deltas.

Growth

45th percentile vs peers
46
Key Signals
Rev Growth YoY 6.7% 50p EPS Growth YoY 3.2% 36p EPS CAGR 3Y 3.0% 45p TSR 13.1% 68p Revenue CAGR 3Y 0.5% 32p
  • FCF Margin in top 20% of peers (16.6%, 88th percentile)
  • Operating Margin in top 20% of peers (21.3%, 94th percentile)
  • ROIC in top 20% of peers (13.3%, 89th percentile)
  • Interest Coverage (EBITDA) in top 20% of peers (16.38, 85th percentile)

No significant risks identified for this axis.

Profitability

80th percentile vs peers
80
Key Signals
Strengths
Risks
Premium
Unlock full Profitability drilldowns

See the signal-level drivers and insights behind this axis. Upgrade to reveal the full Trade-Off Ledger.

Upgrade Now

Safety

61th percentile vs peers
62
Key Signals
Strengths
Safety drilldowns are available to premium members.

Two Futures

Scenario-based fair value ranges for Agilent Technologies, Inc..

Loading scenario defaults...
Loading valuation model...
Unable to Compute Fair Value

This company cannot be valued using standard models.

What this means: The Scenario Theatre requires financial data (revenue, cash flow, shares outstanding) to calculate fair value estimates. This data may be unavailable for:

  • Recently listed companies (IPOs, SPACs)
  • Shell companies or holding companies
  • Companies that haven't filed recent financials
  • Foreign companies with limited data coverage
X.X%
X%XX%
X.X%
-XX%XX%
XX.X%
-XX%XX%
Adjust the sliders above to explore different valuation scenarios.
Unlock Premium
Reveal the full Scenario Theatre
See live sliders, narratives, and full Bear/Base/Bull outcomes.
Upgrade Now
Bear
-
- - -
- upside
-
Base
$43.40
- - -
-74.8% vs current
Snapshot base estimate
Bull
-
- - -
- upside
-
Fair Value Range Current: $-
$- $- $-
Actions & Info
Send Feedback
Please select a category.
0/1000